Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$11.55 - $16.06 $726,448 - $1.01 Million
-62,896 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$12.38 - $29.19 $778,652 - $1.84 Million
62,896 New
62,896 $898,000
Q3 2020

Nov 16, 2020

SELL
$12.34 - $17.92 $227,623 - $330,552
-18,446 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$12.39 - $17.33 $45,297 - $63,358
3,656 Added 24.72%
18,446 $315,000
Q1 2020

May 15, 2020

BUY
$9.12 - $17.78 $134,884 - $262,966
14,790 New
14,790 $195,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.